A detailed history of Jnba Financial Advisors transactions in Johnson & Johnson stock. As of the latest transaction made, Jnba Financial Advisors holds 10,289 shares of JNJ stock, worth $1.6 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
10,289
Previous 11,283 8.81%
Holding current value
$1.6 Million
Previous $1.65 Million 1.09%
% of portfolio
0.17%
Previous 0.17%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$145.48 - $167.38 $144,607 - $166,375
-994 Reduced 8.81%
10,289 $1.67 Million
Q2 2024

Jul 22, 2024

SELL
$144.38 - $157.78 $17,614 - $19,249
-122 Reduced 1.07%
11,283 $1.65 Million
Q1 2024

Apr 26, 2024

SELL
$155.22 - $162.74 $50,136 - $52,565
-323 Reduced 2.75%
11,405 $1.8 Million
Q4 2023

Feb 07, 2024

BUY
$145.6 - $158.88 $69,305 - $75,626
476 Added 4.23%
11,728 $1.84 Million
Q3 2023

Nov 02, 2023

SELL
$155.75 - $174.48 $23,206 - $25,997
-149 Reduced 1.31%
11,252 $1.75 Million
Q2 2023

Aug 03, 2023

SELL
$154.35 - $166.11 $29,172 - $31,394
-189 Reduced 1.63%
11,401 $1.89 Million
Q1 2023

May 01, 2023

BUY
$151.05 - $180.26 $17,823 - $21,270
118 Added 1.03%
11,590 $1.8 Million
Q4 2022

Feb 06, 2023

SELL
$160.2 - $179.79 $267,534 - $300,249
-1,670 Reduced 12.71%
11,472 $2.03 Million
Q3 2022

Nov 07, 2022

SELL
$161.33 - $179.52 $21,940 - $24,414
-136 Reduced 1.02%
13,142 $2.15 Million
Q2 2022

Jul 22, 2022

SELL
$168.19 - $186.01 $75,180 - $83,146
-447 Reduced 3.26%
13,278 $2.36 Million
Q1 2022

Apr 29, 2022

SELL
$158.14 - $179.59 $104,688 - $118,888
-662 Reduced 4.6%
13,725 $2.43 Million
Q4 2021

Feb 03, 2022

BUY
$155.93 - $173.01 $83,734 - $92,906
537 Added 3.88%
14,387 $2.46 Million
Q3 2021

Nov 10, 2021

BUY
$161.5 - $179.47 $484 - $538
3 Added 0.02%
13,850 $2.24 Million
Q2 2021

Aug 04, 2021

BUY
$159.48 - $171.07 $31,736 - $34,042
199 Added 1.46%
13,847 $2.28 Million
Q1 2021

May 03, 2021

BUY
$153.07 - $170.48 $103,628 - $115,414
677 Added 5.22%
13,648 $2.24 Million
Q4 2020

Jan 25, 2021

BUY
$137.11 - $157.38 $19,469 - $22,347
142 Added 1.11%
12,971 $2.04 Million
Q2 2020

Jul 24, 2020

SELL
$128.81 - $155.51 $78,058 - $94,239
-606 Reduced 4.51%
12,829 $1.8 Million
Q1 2020

May 01, 2020

BUY
$111.14 - $153.99 $5,223 - $7,237
47 Added 0.35%
13,435 $1.76 Million
Q4 2019

Feb 10, 2020

BUY
$127.5 - $146.44 $14,917 - $17,133
117 Added 0.88%
13,388 $1.95 Million
Q3 2019

Nov 01, 2019

SELL
$126.95 - $142.14 $15,234 - $17,056
-120 Reduced 0.9%
13,271 $1.72 Million
Q2 2019

Jul 26, 2019

BUY
$131.15 - $144.24 $88,132 - $96,929
672 Added 5.28%
13,391 $1.87 Million
Q1 2019

May 01, 2019

BUY
$125.72 - $139.79 $249,931 - $277,902
1,988 Added 18.53%
12,719 $1.78 Million
Q4 2018

Feb 07, 2019

SELL
$122.84 - $147.84 $3.26 Million - $3.92 Million
-26,518 Reduced 71.19%
10,731 $1.39 Million
Q3 2018

Nov 01, 2018

BUY
$121.58 - $142.88 $3.09 Million - $3.63 Million
25,427 Added 215.08%
37,249 $5.15 Million
Q2 2018

Jul 17, 2018

SELL
$119.4 - $131.76 $13,372 - $14,757
-112 Reduced 0.94%
11,822 $1.44 Million
Q4 2017

Jan 31, 2018

SELL
$131.22 - $143.62 $34,773 - $38,059
-265 Reduced 2.17%
11,934 $1.67 Million
Q2 2017

Aug 14, 2017

BUY
N/A
12,199
12,199 $1.61 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Jnba Financial Advisors Portfolio

Follow Jnba Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Jnba Financial Advisors with notifications on news.